(Q24310873)

Gene Ontology release 2020-05-02

Gene Ontology ID

GO:1904227

positive regulation of glycogen synthase activity, transferring glucose-1-phosphate

GOA release 2020-03-11

1 reference

Gene Ontology release 2020-05-02

Gene Ontology ID

GO:1904228

regulation of glycogen synthase activity, transferring glucose-1-phosphate

1 reference

Gene Ontology release 2020-05-02

Gene Ontology ID

GO:1904226

Glycogen synthase kinase 3 alpha

1 reference

GOA release 2020-03-11

1 reference

1 reference

Theodore P Ciaraldi

1

0 references

Svetlana E Nikoulina

2

0 references

Rahil A Bandukwala

3

0 references

Leslie Carter

4

0 references

Robert R Henry

Inhibition of glycogen synthase kinase-3 by insulin in cultured human skeletal muscle myoblasts

5

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

Endocrinology

0 references

volume

148

0 references

issue

9

0 references

page(s)

4393-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3α and β isoforms in patients with NIDDM

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

“Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Effects of lithium and insulin on glycogen synthesis in L6 myocytes: additive effects on inactivation of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Induction of insulin resistance in human skeletal muscle cells by downregulation of glycogen synthase protein expression

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Isolation and characterization of human muscle cells

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Glycogen Synthase Kinase-3 from Rabbit Skeletal Muscle

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells.

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

GSK-3: tricks of the trade for a multi-tasking kinase

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

New insights into the role and mechanism of glycogen synthase activation by insulin

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Regulation of glycogen synthase kinase-3 in human skeletal muscle: effects of food intake and bicycle exercise

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021

Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.

1 reference

https://api.crossref.org/works/10.1210%2FEN.2006-0932

7 January 2021